ForSight VISION5
researches, develops and commercializes non-invasive products for the treatment of glaucoma and dry eye conditions... Read moreForSight VISION5
researches, develops and commercializes non-invasive products for the treatment of glaucoma and dry eye conditions... Read more
CEO
Andy Corley
News
Jan 09, 2017
BioSpace
ForSight VISION5: <b>ForSight VISION4</b> Release: Biotech Announces Acquisition By Roche
Aug 22, 2016
Fox Business
ForSight VISION5: Allergan Makes an Eye-Opening Acquisition
Aug 17, 2016
4-traders
ForSight VISION5: Allergan to Acquire Eye Care Company ForSight VISION5 Adding Peri-Ocular Ring Technology to Company's Leading Portfolio of Innovative Eye Health...
Aug 14, 2016
The Pharma Letter
ForSight VISION5: Look back at pharma news week to August 12
Aug 13, 2016
Pharmabiz
ForSight VISION5: Allergan to buy US─based eye care company, ForSight VISION5 for $95 million
Aug 11, 2016
TheStreet
ForSight VISION5: Allergan Adds Glaucoma Treatment Maker for $95M
Aug 10, 2016
MassDevice
ForSight VISION5: Allergan picks up ForSight Vision for $95m
May 05, 2016
MassDevice
ForSight VISION5: ForSight Vision5's Helios implant delivers at 6 months in Phase II trial
May 04, 2016
Equities
ForSight VISION5: Silicone ring may be superior to drops for glaucoma patients
Nov 18, 2015
BIOSPACE
ForSight VISION5: <b>ForSight VISION5</b>'s Phase 2 Clinical Data Demonstrating 6-Month IOP-Lowering From A Single Topical Ocular Insert With Very High Retention Rates Presented At American Academy of Ophthalmology; Company Anticipates Start Of Phase 3 Clinical Program In 2016
ForSight VISION5 Competitors
1
2
3
4
5
6
7
8
9
10